Lynne Kelley
Equibles does not estimate personal net worth.
Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get CNSP alertsAbout Lynne Kelley
CNS Pharmaceuticals, Inc. reported in an 8-K filed March 2, 2026 that Lynne Kelley was appointed Chief Medical Officer, effective March 2, 2026. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Rami Levin (CEO and Board Member), Faith Charles (Chairman and Board Member), Steve O'Loughlin (CFO) and 7 others.
“On February 26, 2026, CNS Pharmaceuticals, Inc. (the "Company") entered into an employment agreement (the "Employment Agreement") with Lynne Kelley to serve as the Company's Chief Medical Officer effective March 2, 2026.”
Affiliation history
-
CNS Pharmaceuticals, Inc. (CNSP)
Proxy statement
Current2026-03-02–present
Last confirmed August 21, 2026
Company network
Leadership on record at CNS Pharmaceuticals, Inc.
- Rami Levin CEO, Board Member
- Faith Charles Chairman, Board Member
- Steve O'Loughlin CFO
- Eric Faulkner CTO
- Amy Mahery Board Member
- Bettina Cockroft Board Member
- Bettina M. Cockroft, M.D., M.B.A. Board Member
- Faith L. Charles Board Member
- Jeff Keyes Board Member
- Jeffrey Keyes Board Member